|
WSWS : News
& Analysis : North
America
Bush administration proposes crippling cuts in Medicare
By Kate Randall
10 October 2002
Use
this version to print
| Send this
link by email | Email the
author
The Bush administration is proposing drastic cuts in Medicare
payments for a wide range of drugs and medical services beginning
next year. The Medicare program, a social insurance program established
in 1965, provides medical care to the elderly and the disabled,
and is the only source of medical care for the majority of American
seniors.
Medicare benefits are already woefully inadequate, forcing
many to pay for supplemental insurance or go without needed care
and medications. The new reductions will undoubtedly result in
denial of access to care for hundreds of thousands of American
seniors, as government payments are slashed for vitally needed
drugs and services, forcing hospitals to stop offering many medical
treatments. The new rates are scheduled to take effect January
1, 2003.
The Medicare payment reductions are mainly aimed at outpatient
services, which account for nearly half of all revenue at many
US hospitals. Medicare received more than 110 million claims for
outpatient services in 2001. Advances in medical technology have
greatly increased the numbers of procedures which can now be performed
on an outpatient basis, reducing overnight stays at the hospital.
Procedures and drugs targeted include cancer drugs, blood products,
cardiac pacemakers and defibrillators, breast biopsies and emergency
room treatment for heart attacks, among many others. Examples
of the proposed cuts include the following:
* Medicare payment for a unit of blood cells would be cut by
39 percent, from $137 this year to $83 next year.
* The procedure for inserting a battery-operated pacemaker
and defibrillator would be cut by 59 percent, from $29,360 to
$12,102.
* Payment for a breast biopsya procedure used to detect
breast cancer and other conditionsto be cut 27.5 percent,
from $400 to $290.
* Payment for Avonexan injectable drug used to treat
multiple sclerosisto be reduced from $255 to $144, a 36
percent cut.
* Payment for implanting an infusion pump to deliver medication
to manage severe pain would be cut by 67 percent, from $4,079
to $1,346.
* Payment for the typical treatment for a hemophiliac would
be reduced by more than half, from $2,800 to $1,300.
Under Medicare, hospitals receive a fixed amount of funds,
determined in advance, for each outpatient service. Similar services
are grouped in categories, with the government setting standard
payments for each group. The government says it is basing its
new payment structure on data from claims submitted by hospitals.
Critics of the new system, however, argue that hospitals often
underreport the costs of high-tech products and procedures, marking
up their charges more for these than for low-cost items such as
bandages or aspirin. Under the proposed cuts, a uniform, across-the-board
reduction would be applied, resulting in an underestimation of
the actual cost of high-cost, high-tech services. If hospitals
are unable to cover their costs, or are unwilling to accept a
lower profit-margin, patients will be denied service.
The Advanced Medical Technology Association (AdvaMed) called
the proposed cuts excessive, writing in an August
7 press release: AdvaMed is concerned that CMS [Centers
for Medicare & Medicaid Services] flawed data and methodology
have caused the agency to grossly underestimate the cost of some
advanced medical technologies. In fact, for some high-tech procedures
the 2003 payment would be lower than the 2001 rates that failed
to recognize the cost of utilizing those technologies.
Cancer patients will be especially hard hit. The Association
of Community Cancer Centers (ACCC) includes hospitals, physicians,
nurses, social workers and oncology team members that provide
services to more than 60 percent of all US cancer patients. ACCC
says that under the Bush administrations proposal, reimbursement
for cancer drugs would decrease by $286 million, a 38 percent
reduction from 2001 rates.
In an October 7 letter to the Centers for Medicare & Medicaid
Services, ACCC said the cuts will have grave implications
for patients battling cancer, and that the proposal threatens
patient access to the most appropriate care in hospital outpatient
departmentsa setting that is a crucial part of our nations
cancer care infrastructure.
In addition to the proposed cuts in reimbursements for outpatient
procedures, Medicare recipients face further attacks on services,
with 23 health plans announcing they will drop out of Medicare
or reduce their service areas in 2003. Close to 200,000 seniors
will be dropped by health maintenance organizations (HMOs) which
will stop participating in the Medicare+Choice program. The HMOs
blame their decision to leave the program on inadequate government
reimbursement.
About 5 million, mostly low-income, seniors are enrolled in
Medicare+Choice plans, which provide additional benefits, such
a coordination of care and prescription drug coverage, reducing
some out-of-pocket expenses. Seniors unable to enroll in other
Medicare+Choice plans will be forced to return to traditional
fee-for-service Medicare. Last year, 58 health plans withdrew
or cut services from Medicare+Choice, affecting about 536,000
seniors.
American teaching hospitals are already facing Medicare-related
cuts mandated in 1997 under the Balance Budget Revision Act, which
reduced extra fees charged to Medicare by the hospitals. The reductions,
which went into effect October 1, will cut funding to the teaching
facilities by $800 million in fiscal year 2003 and could amount
to more than $4 billion in losses over the next five years.
While they make up only 20 percent of US hospitals, the nations
1,100 teaching hospitals conduct two-thirds of all highly specialized
surgeries and treat nearly half of all patients with highly specialized
diagnoses. They train more than 100,000 resident physicians each
year and also supply more than 70 percent of hospital care to
the 43 million Americans with no health insurance.
With Congress having failed to pass a Medicare prescription
drug bill, the Senate is now considering a stopgap funding measure
for Medicare providers. Under pressure from hospitals, doctors,
HMOs and other medical providers, the Senate is considering a
$44 billion package to make up for some of the funding cut by
the 1997 balanced budget legislation.
A number of patient advocacy groups have criticized the proposal
for helping the health care industry while ignoring beneficiaries.
Ellen Stovall, president of the National Coalition for Cancer
survivorship, commented, Once the cancer community understands
that the Senate leadership is prepared to offer more than $40
billion in so-called provider givebacks and nothing for people
with cancer, they will be very angry.
See Also:
Another debacle for US
health care
Congress fails to adopt prescription coverage for the elderly
[9 August 2002]
Patients Bill
of Rights: not even a band-aid for US health care crisis
[7 July 2001]
Top of page
The WSWS invites your comments.
Copyright 1998-2008
World Socialist Web Site
All rights reserved |